Bone Biologics Corporation Profile Avatar - Palmy Investing

Bone Biologics Corporation

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides tar…

Medical - Devices
US, Burlington [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Bone Biologics Corporation mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of BBLG's Analysis
CIK: 1419554 CUSIP: 098070303 ISIN: US0980705018 LEI: - UEI: -
Secondary Listings
BBLG has no secondary listings inside our databases.